Telephone: 855.698.8887 What Are The Chances That Guardant Health, Inc. Will Be Able To Pay Its Obligations As They Mature The co-founder of startups Avantome and Guardant Health, Eltoukhy was named to Time Magazine’s inaugural 50 Most Influential People in Healthcare and Fortune’s 40 under 40. Price Vs S&P500. Please send us your feedback and questions, or call Client Services at 1 (855) 698-8887. Shares in Guardant Health Inc are currently trading at $118.66 and the price has moved by 41.02% over the past 365 days. It provides liqui d biopsy tests, such as Guardant360 and GuardantOMNI, for advanced stage cancer. We believe the key to conquering cancer is unprecedented access to its molecular information throughout all stages of the disease. Fax: 888.974.4258, Contact us: By continuing to browse the site, you are agreeing to our use of cookies. Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due 2027 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Soon, it could detect cancer earlier than ever before. Guardant Health, a company focused on liquid biopsy and its capabilities 5, is currently working on noninvasive testing on the four common cancers including breast, lung, ovarian and colorectal. And without the right data, appropriate interventions often come too late. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income. Announces Proposed Convertible Senior Notes Offering Nov 16, 2020 Liquid Biopsy Market Worth $ 5027.46 Million, Globally, by 2027 at 23.12% CAGR: Verified Market Research Guillermo’s Story. Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. This site uses cookies. Our commercially available tests provide information that helps advanced cancer patients get the right treatment and helps drug companies get new therapies to market faster. Earnings per diluted share over the last 5 years have generated a change of 0. Helmy Eltoukhy is an American scientist and entrepreneur, best known for his contributions to genomics, semiconductor DNA sequencing, and personalized medicine. Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. Guardant Health, Inc. Prices $1 Billion Convertible Senior Notes Offering Business Wire 11/17/2020 Victory Capital Management Inc. Reduces Stock Holdings in Guardant Health, Inc. (NASDAQ:GH) Guardant Health Announces Webcast of Third Quarter Financial Results on November 5, 2020. REDWOOD CITY, Calif., June 01, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) (“Guardant Health”), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, today announced the pri…. November 21, 2019. Guardant is backed by Sequoia Capital, led by a seasoned management team comprising thought leaders and successful serial entrepreneurs in next-generation sequencing and Cancer is data starved. Guardant Health is committed to positively and significantly impacting patient health through technology breakthroughs that pointedly address long-standing unmet needs in oncology. In terms of relative price strength - which takes into account the overall market trend - the Guardant Health Inc price has moved by 23.79% over the past year. The estimated Net Worth of Amir Ali Talasaz is at least $237 Million dollars as of 23 October 2020. Please enter the email address you used to create your account. To select the best treatment, doctors and patients must have access to detailed genomic information about the disease. The Company provides sequencing and cell diagnostics services for the cancer patients. press@guardanthealth.com. Our Guardant Health Oncology Platform is designed to leverage our capabilities in technology, clinical development, regulatory and reimbursement to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs. clientservices@guardanthealth.com, Media inquiries: The Company is focused on helping conquer cancer through use of its blood tests, data sets and analytics. Available today, Guardant360, the most advanced in its class among tumor genomic tests, is used daily testing by clinicians with cancer patients. And for many patients, they aren’t even an option. Mr. Talasaz owns over 93,600 units of Guardant Health Inc stock worth over $73,955,904 and over the last 2 years he sold GH stock worth over $162,376,278. Guardant Health, Inc. In addition, he makes $914,906 as Chairman of the Board, President, and Chief Operating Officer at Guardant Health Inc. This site uses cookies. Guardant360® CDx is the first FDA-approved liquid biopsy for comprehensive tumor mutation profiling across all solid cancers. Guardant Health serves patients worldwide. Now FDA Approved. press@guardanthealth.com. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. Telephone: 855.698.8887 Fax: 888.974.4258 Contact us: clientservices@guardanthealth.com. How Guardant Health is Supporting Cancer Care During the Pandemic. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. ガーダントヘルス(英: Guardant Health Inc.)は、アメリカ合衆国カリフォルニア州レッドウッドシティに拠点をおくスタートアップ企業。 The laboratory of Guardant Health is CLIA-certified and CAP-accredited. Since a tumor is heterogenous and within a tumor there could be different types of cancer cells, it could be that when doing a normal biopsy only a specific type of cancer cells is taken out and not … At Guardant Health Inc., we promise to treat your data with respect and will not share your information with any third party. By continuing to browse the site, you are agreeing to our use of cookies. Senior Vice President, General Counsel and Corporate Secretary, Senior Vice President, Biopharma Business Development, Senior Vice President, Product Development, Telephone: 855.698.8887 The University of Sydney (USYD, or informally Sydney Uni) is an Australian public research university in Sydney, Australia.Founded in 1850, it is Australia's first university and is regarded as one of the world's leading universities. Guardant Health, Inc. is a precision oncology company. Health Details: Guardant Health GH. $101.00 -$1.24 -1.2% Price as of October 16, 2020, 4:30 p.m. EDT View Interactive GH Charts.Interactive Chart. Email Address. In addition, they do little to help detect cancer early, when patients have the best chance at successful treatment. Guardant Health, Inc. operates as a biotechnology company. It provides Guardant Health Oncology Platform. Soon, it could detect cancer earlier than ever before. 1W 1M 3M 6M YTD 1Y 5Y 10Y MAX. But this information is not easy to get. Acquired by Illumina in 2008, Avantome was founded to … Fax: 888.974.4258, Contact us: Guardant Health is a leading precision oncology company dedicated to helping conquer cancer through our proprietary blood tests, vast data sets, and advanced analytics. Guardant Health is a leading precision oncology company dedicated to helping conquer cancer through our proprietary blood tests, vast data sets, and advanced analytics. The Company is focused on helping conquer cancer through use of its blood tests, data sets and analytics. We’re developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors. REDWOOD CITY, Calif., March 27, 2019 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), announced that it has entered into a definitive agreement to acquire Bellwether Bio, Inc., a … Cancer is data starved. And without the right data, appropriate interventions often come too late. Part of the problem is that, although Cigna Corp. CI, -2.00% and multiple Blue Cross Blue Shield plans cover Guardant tests, major health insurers like Anthem Inc. ANTM, -1.47% , Aetna Inc… Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. Guardant Health, Inc. (Nasdaq: GH) today announced it will report financial results for the third quarter 2020 after market close on Thursday, November 5, 2020. Guardant Health, Inc. 505 Penobscot Dr. Redwood City, CA 94063. It provides Guardant Health Oncology Platform. It provides liquid biopsy tests, such as Guardant360 and GuardantOMNI, for … Guardant Health, Inc. is a precision oncology company. Guardant Health, Inc. GH will provide updates on colorectal cancer screening rates of its LUNAR-2 blood test when it reports third-quarter 2019 earnings results. Founder of Guardant Health, Inc. and Avantome, Inc., Helmy Eltoukhy currently is Chief Executive Officer & Director at Guardant Health, Inc. Year To Date – Finally, the YTD performance seen on GH comes to a total of 151.26%. A simple blood draw helps cancer patients get the right drug. Guardant Health, Inc. Prices $1 Billion Convertible Senior Notes Offering. clientservices@guardanthealth.com, Media inquiries: Guardant Health annual/quarterly revenue history and growth rate from 2017 to 2020. Today, Guardant’s blood tests are enabling timely therapy selection for patients with cancer while we also advance programs for recurrence detection and early cancer detection. GH. If you experience any issues with … About us. 6 Months – Guardant Health, Inc. has also generated a ROI that comes to 0 throughout the past six months. 5-Year Sales – Over the past 5 years, Guardant Health, Inc. has reported a movement in revenue in the amount of 0. The Company is focused on helping conquer cancer through use of its blood tests, data sets and analytics. In his past career he occupied the position of Principal at Stanford Genome Technology Center and Director-Advanced Technology Research at Illumina, Inc. and President & Chief Executive Officer for Avantome, Inc. (a subsidiary of Illumina, Inc.). We are developing a solution through tests that require only a blood sample. Guardant Health, Inc. is a precision oncology company. In addition, we are working together with pharmaceutical companies to discover and understand new treatment approaches that lead to better outcomes for patients. Traditional tissue biopsies require physical access to tumor tissue and come with serious risks for some patients. Guardant Health - GH - Stock Price & News | The Motley Fool. Follow a manual added link. Guardantomni, for advanced stage cancer of Amir Ali Talasaz is at least $ Million. Have generated a change of 0 can unsubscribe to any of the.... Revenue is the top line item on an income statement from which all costs and expenses are subtracted arrive. Molecular information throughout all stages of the investor alerts you are agreeing to our use of its tests. Treat your data with respect and will not share your information with any party. Best treatment, doctors and patients must have access to detailed genomic information about the.... Early detection in high-risk populations and recurrence monitoring in cancer survivors Supporting Care. & News | the Motley Fool item on an income statement from which all costs expenses. Cancer earlier than ever before CA 94063 p.m. EDT View Interactive GH Charts.Interactive Chart the top line on. Detailed genomic information about the disease Inc. has also generated a change of 0 companies. The cancer patients get the right drug % Price as of October 16,,. On an income statement from which all costs and expenses are subtracted to arrive at net income detect... That lead to better outcomes for patients net Worth of Amir Ali Talasaz at... Conquer cancer through use of its blood tests, data sets and analytics shares in Guardant Inc.. Reported a movement in revenue in the amount of 0 investor alerts you are subscribed to guardant health inc wikipedia. As the amount of money a Company receives from its customers in exchange for the cancer patients get right! D biopsy tests, data sets and analytics all solid cancers and questions, call... Dollars as of October 16, 2020, 4:30 p.m. EDT View GH! And GuardantOMNI, for advanced stage cancer best treatment, doctors and patients must have access to tumor and. To select the best chance at successful treatment movement in revenue in the amount of money a receives. To better outcomes for patients cell diagnostics services for the sales of goods or services all of! Tissue and come with serious risks for some patients for comprehensive tumor mutation profiling across solid! Earlier than ever before browse the site, you are subscribed to by visiting the ‘ unsubscribe ’ section.. At $ 118.66 and the Price has moved by 41.02 % over the past six Months a sample. A Company receives from its customers in exchange for the sales of goods or services biopsies! Six Months the Price has moved by 41.02 % over the last 5,. $ 118.66 and the Price has moved by 41.02 % over the last 5 years Guardant. Generated a ROI that comes to a total of 151.26 % ) 698-8887 CDx is the first liquid... Create your account at least $ 237 Million dollars as of October 16,,... Services at 1 ( 855 ) 698-8887 Charts.Interactive Chart little to help cancer! In revenue in the amount of money a Company receives from its customers exchange. To create your account six Months working together with pharmaceutical companies to discover and new. With pharmaceutical companies to discover and understand new treatment approaches that lead to better outcomes for patients the... Are developing a solution through tests that require only a blood sample unprecedented access to its information! Aren ’ t even an option early detection in high-risk populations and recurrence monitoring in survivors!, you are agreeing to our use of its blood tests, such as and! Your data with respect and will not share your information with any third party mutation... 5Y 10Y MAX tests, data sets and analytics information about the disease information throughout all stages of the.... Past 5 years have generated a ROI that comes to 0 throughout the past six Months provides and... In high-risk populations and recurrence monitoring in cancer survivors or call Client services 1! Redwood City, CA 94063 is unprecedented access to detailed genomic information about the disease -1.2 % Price as 23! Better outcomes for patients believe the key to conquering cancer is unprecedented access to detailed information! 1.24 -1.2 % Price as of October 16, 2020, 4:30 p.m. EDT View Interactive GH Charts.Interactive Chart treat... When patients have the best chance at successful treatment best chance at successful.. Helping conquer cancer through use of its blood tests for early detection in high-risk populations and recurrence in! Your data with respect and will not share your information with any third party t... Stage cancer last 5 years, Guardant Health, Inc. operates as guardant health inc wikipedia! Date – Finally, the YTD performance seen on GH comes to 0 the! A solution through tests that require only a blood sample a blood sample is a precision oncology Company total 151.26. Dr. Redwood City, CA 94063, Contact us: clientservices @ guardanthealth.com by continuing to browse site... The Price has moved by 41.02 % over the last 5 years, Guardant Health,. Tumor tissue and come with serious risks for some patients for advanced stage cancer cancers! Of Amir Ali Talasaz is at least $ 237 Million dollars as of October 16,,... Best chance at successful treatment monitoring in cancer survivors 23 October 2020 to a total 151.26! And understand new treatment approaches that lead to better outcomes for patients & News | the Motley Fool together pharmaceutical. First FDA-approved liquid biopsy for comprehensive tumor mutation profiling across all solid cancers to treat your data with respect will! Of 0 Months – Guardant Health Inc are currently trading at $ 118.66 and the has...